Renal Function Tests Market - Introduction
Kidneys are among the most vital organs of the human body. Kidneys act as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Since kidneys play such an important role, these require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth.
Functional damage of kidneys is common across the world, and its incidence is increasing globally. High blood pressure, hypertension, diabetes, excessive alcohol consumption, frequent urges to urinate, blood in urine, difficulty in urination, and puffiness in the hands and feet due to buildup of fluids in the body are the major symptoms and causative factors of chronic kidney disease. Renal function tests measure the amount of certain substances released into the blood or urine by the kidneys. The kidney function tests are performed to identify the renal disease to determine appropriate patient management and prevent further deterioration of renal function.
Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Renal Function Tests Market – Competitive Landscape
• In October 2018, Siemens Healthineers AG entered an original equipment manufacturer (OEM) alliance with Israel-based Healthy.io Company. The alliance aimed at integration of urinalyses reagents of former company into smartphone-based urinalysis system of Healthy.io. To provide patients with increased access to home based urinalysis testing for detection of chronic kidney disease.
• Siemens Healthineers formed a strategic alliance with the National Kidney Foundation and to offer no-cost urine testing to patients with high risk of kidney disease in the U.S. This is anticipated to improve the diagnosis and treatment of kidney disease and strengthen its geographic presence.
Siemens Healthineers AG
Founded in 1847, Siemens Healthineers AG is a global provider of health care solutions and services. The company develops, manufactures, and sells a diverse range of market-leading and innovative diagnostic, imaging, and advanced therapy products and services to healthcare providers around the world. The company focuses on investment in R&D to develop products for the effective treatment of renal disorders as well as engage in strategic collaborations to create awareness and foster adoption of kidney function tests.
1. Hoffmann-La Roche
Incorporated in 1896, F. Hoffmann-La Roche is based in Basel, Switzerland. F. Hoffmann-La Roche Ltd. is a prominent biotechnology company that develops and markets breakthrough medicines and diagnostic solutions across various medical specialties. The company operates through two major divisions: pharmaceutical and diagnostics. The company offers diverse products and solutions in the fields of clinical chemistry & immunoassay, molecular diagnostics, tissue diagnostics, point-of-care diagnostics, and hematology and hemostasis. It provides various test kits such as Chemstrip test or Combur-Test for the detection of albumin in urine for early diagnosis of chronic kidney disease.
Other prominent players operating in the global renal function tests market are Sysmex Corporation, OPTI Medical, Beckman Coulter, ARKRAY, Nova Biomedical, 77 Elektronika, Abbott, Metabolic Solutions Development Company, LLC, IDEXX Laboratories, URIT Medical, Randox Laboratories, and Otsuka Holdings Co., Ltd., among others.
Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=C...
Renal Function Tests Market - Dynamics
Rise in Incidence of Chronic Kidney Disease Globally Drives Market
Increase in incidence of chronic kidney diseases (CKD) across the globe is a major factor driving the global renal function tests market. For instance, 1 in 4 men and 1 in 5 women aged 65 years and above suffer from chronic kidney disease across the globe. Currently, 10% to 15% of the global population is affected with chronic kidney disease. According to the World Health Organization, each year, more than 1.4 million people across the world undergo kidney replacement therapy, with the incidence rate of chronic kidney disease increasing by nearly 8% annually. Moreover, according to Kidney Care UK, currently, 3 million people are affected by chronic kidney disease in the U.K. All these factors are anticipated to boost the demand for renal function tests in the near future.
Growing Prevalence of Diabetes Propels Renal Function Tests Market
Hypertension and diabetes are the most common causes of chronic kidney disease. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 1 in 4 adults suffering from diabetes have chronic kidney disease. Based on National Kidney Foundation, approximately 35% of people aged 20 years and above living with diabetes have chronic kidney disease. Additionally, diabetes led to more than 51,000 new cases of kidney failure in 2013 in the U.S. Hence, rise in prevalence of diabetes and increase in elderly patient pool are the other major factors likely to boost demand for renal function tests during the forecast period. However, high cost of treatment and complications including exposure to radiation during glomerular filtration rate tests are likely to restrain the market during the forecast period.
Pre Book: https://www.transparencymarketresearch.com/checkout.php?rep_id=6809...
North America Dominates the Renal Function Tests Market while Asia Pacific to Provide Lucrative Growth Opportunities
North America is projected to account for dominant share of the global market between 2019 and 2027. This is attributed to rise in prevalence of chronic kidney disease and favorable government support for early diagnosis and treatment in the U.S. For instance, 1 in 3 adults in the U.S. is at high risk of developing chronic kidney disease. This is attributed to various factors such as high blood pressure, diabetes, family history of kidney failure, and high geriatric population aged 60 years and above.
The renal replacement market in Asia Pacific is expected to grow at a rapid pace owing to adoption of western and sedentary lifestyle, increase in incidence of diabetes, rise in baby boomer population, and excessive alcohol consumption in emerging countries such as India and China.

More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/mhealth-services-market-to...

https://www.prnewswire.com/news-releases/molecular-diagnostics-mark...

https://www.prnewswire.com/news-releases/single-use-centrifuge-syst...

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/